Hoshino, Masahiro
Yang, Seokhun
Sugiyama, Tomoyo
Zhang, Jinlong
Kanaji, Yoshihisa
Hamaya, Rikuta
Yamaguchi, Masao
Hada, Masahiro
Horie, Tomoki
Nogami, Kai
Ueno, Hiroki
Misawa, Toru
Yonetsu, Taishi
Hwang, Doyeon
Lee, Joo Myung
Shin, Eun-Seok
Doh, Joon-Hyung
Nam, Chang-Wook
Koo, Bon-Kwon
Sasano, Tetsuo
Kakuta, Tsunekazu
Funding for this research was provided by:
St. Jude Medical
Article History
Received: 27 August 2020
Revised: 19 February 2021
Accepted: 18 March 2021
First Online: 19 May 2021
Declarations
:
: The scientific guarantor of this publication is Dr. Tsunekazu Kakuta.
: The authors of this manuscript declare relationships with the following companies: Dr. Bon-Kwon Koo received an institutional research grant from St. Jude Medical (Abbott Vascular) and Philips Volcano. Dr. Joo Myung Lee received a research grant from St. Jude Medical (Abbott Vascular) and Philips Volcano. All other authors declare that there is no conflict of interest relevant to the submitted work.
: One of the authors has significant statistical expertise.Dr. Rikuta Hamaya kindly provided statistical advice for this manuscript.
: Written informed consent was obtained from all patients in this study.
: Institutional Review Board approval was obtained.
: The present study is the substudy of the multicenter study CCTA-FFR Registry for Risk Prediction, Clinical Trial Registration Information: NCT04037163, and the study population was derived from the institutional CCTA registry of Tsuchiura Kyodo General Hospital, one of the cardiac centers that participated in the aforementioned international multicenter registry. Some study subjects have been previously reported in J Cardiovasc Comput Tomogr. 2020 Feb 6:S1934-5925(19)30733-6.
: • retrospective• cross-sectional multicenter study